Characteristics | n (%) |
---|---|
Age | |
Median 95% CI (years) | 54 (52.1-57.4) |
Performance status (ECOG scale) | |
0 | 6 (13.1%) |
1 | 37 (80.4%) |
2 | 3 (6.5%) |
FIGO stage at diagnosis | |
IIIA | 4 (8.7%) |
IIIB | 8 (17.4%) |
IIIC | 20 (43.5%) |
IV | 14 (30.4%) |
Histologic cell type | |
Serous | 24 (52.2%) |
Endometrioid | 10 (21.7%) |
Mucinous | 3 (6.5%) |
Clear cell | 2 (4.3%) |
Mixed | 6 (13.1%) |
Undifferentiated | 1 (2.2%) |
Grade | |
G1 and G2 | 21 (45.6%) |
G3 and unknown | 25 (54.4%) |
Primary surgery (with interval surgery) | |
Optimal debulking | 27 (58.7%) |
Suboptimal debulking | 19 (41.3%) |
Platinum sensitivity | |
Sensitive (>6 months) | 31 (67.4%) |
Resistant (<6 months) | 15 (32.6%) |